Concert Pharmaceuticals Price on December 31, 2022

CNCEDelisted Stock  USD 8.37  0.01  0.12%   
If you're considering investing in Concert Stock, it is important to understand the factors that can impact its price. As of today, the current price of Concert Pharmaceuticals stands at 8.37, as last reported on the 28th of November, with the highest price reaching 8.55 and the lowest price hitting 8.35 during the day. We have found twenty-nine technical indicators for Concert Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Concert Pharmaceuticals' Mean Deviation of 2.79, risk adjusted performance of 0.1565, and Downside Deviation of 2.74 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Concert Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
CNCE
Based on monthly moving average Concert Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Concert Pharmaceuticals by adding Concert Pharmaceuticals to a well-diversified portfolio.

Concert Pharmaceuticals Valuation on December 31, 2022

It is possible to determine the worth of Concert Pharmaceuticals on a given historical date. On December 31, 2022 Concert was worth 5.33 at the beginning of the trading date compared to the closed value of 5.84. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Concert Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Concert Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Concert Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Concert Pharmaceuticals' related companies.
 Open High Low Close Volume
  4.86    5.62    4.85    5.41    436,847  
12/30/2022
  5.33    5.90    5.24    5.84    707,799  
  5.90    6.35    5.86    5.98    706,104  
Backtest Concert Pharmaceuticals  |  Concert Pharmaceuticals History  |  Concert Pharmaceuticals Valuation   PreviousNext  
Open Value
5.33
5.84
Closing Value
5.33
Upside

Concert Pharmaceuticals Trading Date Momentum on December 31, 2022

On January 03 2023 Concert Pharmaceuticals was traded for  5.98  at the closing time. The top price for the day was 6.35  and the lowest listed price was  5.86 . The trading volume for the day was 706.1 K. The trading history from January 3, 2023 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 2.40% . The overall trading delta against the current closing price is 20.55% .

Concert Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Concert Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Concert Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Concert financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Concert Pharmaceuticals Stock history

Concert Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Concert is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Concert Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Concert Pharmaceuticals stock prices may prove useful in developing a viable investing in Concert Pharmaceuticals
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. Concert Pharmaceutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 64 people.

Concert Pharmaceuticals Stock Technical Analysis

Concert Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Concert Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Concert Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Concert Pharmaceuticals Period Price Range

Low
November 28, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Concert Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Concert Pharmaceuticals November 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Concert Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Concert Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Concert Pharmaceuticals stock market strength indicators, traders can identify Concert Pharmaceuticals entry and exit signals to maximize returns

Concert Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Concert Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Concert Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Concert to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Consideration for investing in Concert Stock

If you are still planning to invest in Concert Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Concert Pharmaceuticals' history and understand the potential risks before investing.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges